Specificity of Cell-Mediated Immunoreactivity in Melanoma and Comments on the Nature of Serum Blocking Factors
Reference49 articles.
1. Avis, F., Avis, I., Newsome, J. F., and Haughton, G., 1976, Antigenic cross-reactivity between adenocarcinoma of the breast and fibrocystic disease of the breast, J. Natl. Cancer Inst. 56: 17. 2. Baldwin, R. W., Price, M. R., and Robins, R. A., 1972, Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes, Nature (London) New Biol. 238 :185. 3. Burger, D. R., Vandenbark, A. A., Finke, P., Malley, A., Frikke, M., Black, J., Acott, K., Begley, D., and Vetto, R. M., 1977, Assessment of reactivity to tumor extracts by leukocyte adherence inhibition and dermal testing, J. Natl. Cancer Inst. 59:317. 4. Creemers, P., 1977, The role of leukocyte subpopulations in the indirect leukocyte adherence inhibition assay in the mammary tumor virus system, Eur. J. Immunol. 7:48. 5. Dunn, I. S., and Halliday, W. J., 1980, Interactions between T and B lymphocytes and macrophages in the production of leukocyte adherence inhibition factor, Cell. Immunol. 52:48.
|
|